| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 6e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |